Table 4.
Changes from baseline to day 28 for each variable in the fistuloclysis subgroups.
| Variables | Group 1 (n = 11) | Group 2 (n = 16) | Group 3 (n = 8) | P value |
|---|---|---|---|---|
| TB (μmol/L) | 13.8 ± 4.1 | 24.3 ± 8.9 | 18.4 ± 5.6 | 0.011* |
| DB (μmol/L) | 10.1 ± 3.2 | 14.1 ± 5.0 | 13.2 ± 4.8 | 0.040* |
| IB (μmol/L) | 3.7 ± 0.8 | 9.5 ± 3.6 | 4.3 ± 1.2 | <0.001* |
| ALT (U/L) | 10.5 ± 2.5 | 4.4 ± 1.7 | 10.3 ± 2.8 | <0.001* |
| ALP (U/L) | 77.4 ± 24.9 | 111.9 ± 32.7 | 102.6 ± 31.7 | 0.022* |
| GGT (U/L) | 144.2 ± 50.8 | 164.2 ± 58.5 | 158.3 ± 60.3 | 0.330 |
| TP (g/L) | 17.8 ± 6.2 | 25.7 ± 10.8 | 21.3 ± 9.8 | 0.005* |
| Alb (g/L) | 7.5 ± 2.3 | 14.3 ± 5.4 | 9.4 ± 3.2 | 0.020* |
| WBC (109/L) | 2.5 ± 1.1 | 2.7 ± 1.1 | 2.6 ± 1.3 | 0.884 |
| CRP (mg/L) | 2.1 ± 0.7 | 2.8 ± 0.8 | 2.4 ± 0.7 | 0.120 |
| Fistula output (mL/day) | 755.4 ± 160.2 | 830.3 ± 231.5 | 770.0 ± 215.6 | 0.232 |
Group 1: patients with jejunal-ileal fistula; Group 2: patients with biliary fistula; Group 3: patients with duodenal fistula. EF: enteric fistula; TB: total bilirubin; DB: direct bilirubin; IB: indirect bilirubin; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT:γ-glutamyltransferase; TP: total protein; Alb: albumin; WBC: white blood cells; CRP: C-reactive protein. Data were presented as mean ± SD. P value < 0.05 was deemed significant.